MedPath

A Randomized, Double Blind, Comparative Study Of STATUS D3Ⓡ (vitamin D3) Versus Placebo In Children Aged Between 7 And 15 Years Old to prevent infectious diseases including influenza and to improve atopic dermatitis

Not Applicable
Conditions
elementary shool, junior high school children
Registration Number
JPRN-UMIN000001373
Lead Sponsor
Jikei University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1.already taking vitamin D3 or active form of vitamin D 2.past history of urethral stone, or having underlying diseases related with calcium and/or bone metabolism 3.known allergy to sesame, gelatin, d-solvitor, 4.difficulty in swallowing capsules for 4 months 5.during or within 1 year after chemotherapy or immunocompromised conditions 6.known to move during study period 7.other reasons that doctor judges impossible to attend the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
doctor-diagnosed influenza
Secondary Outcome Measures
NameTimeMethod
gastric enteritis, febrile diseases, admission to hospital, absent days from school, changes of child behavior check list and improvement of atopic dermatitis
© Copyright 2025. All Rights Reserved by MedPath